SCHEDULE 13G: Intracoastal Capital and Affiliates Disclose 9.99% Stake in SeaStar Medical Holding Corporation

Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, has disclosed a passive beneficial ownership of 9.99% in SeaStar Medical Holding Corporation's common stock.

Summary

• Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC (collectively, the "Reporting Persons") have filed a Schedule 13G, indicating beneficial ownership in SeaStar Medical Holding Corporation.
• As of June 27, 2025, the Reporting Persons collectively beneficially own 1,803,026 shares of SeaStar Medical Holding Corporation's common stock.
• This ownership represents approximately 9.99% of the company's common stock.
• The shares beneficially owned consist of 1,346,154 shares issuable upon exercise of Intracoastal Warrant 2 and 456,872 shares issuable upon exercise of Intracoastal Warrant 3.
• The calculation of beneficial ownership is based on 11,203,752 shares of common stock outstanding as of June 12, 2025, plus 4,935,385 shares issued at the closing of the Securities Purchase Agreement (SPA) and 106,154 shares issued upon exercise of Intracoastal Warrant 1, in addition to the shares from Intracoastal Warrant 2 and 3.
• The filing notes that various warrants (Intracoastal Warrant 1, 2, 3, 4, and 5) contain 'blocker provisions' preventing the holder from exercising them to the extent that beneficial ownership would exceed 9.99% (or 4.99% for Intracoastal Warrant 5).
• Without these blocker provisions, the Reporting Persons would have been deemed to beneficially own 4,138,247 shares immediately following the SPA on June 20, 2025, and 2,792,093 shares as of June 27, 2025.
• The filing certifies that the securities were not acquired and are not held for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not convey explicit positive or negative sentiment regarding the company's performance or prospects. It is a neutral regulatory filing.

Positives

• Increased institutional ownership by Intracoastal Capital and its principals may signal confidence in SeaStar Medical Holding Corporation's long-term prospects.
• The acquisition of shares and warrants through a Securities Purchase Agreement indicates a recent capital infusion into the company.

Future Outlook

This Schedule 13G filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing indicates a significant passive investment by an institutional entity in a publicly traded company, which is a common occurrence in the financial markets. It reflects an investor's decision to take a substantial, but non-controlling, stake in a company, often signaling a belief in its long-term value.

Stakeholder Impact

• Shareholders may view the significant stake taken by an institutional investor as a positive signal, potentially increasing investor confidence and liquidity in the stock.

Key Dates

Keywords

SeaStar Medical Holding Corporation, Intracoastal Capital LLC, Mitchell P. Kopin, Daniel B. Asher, Schedule 13G, Beneficial Ownership, Common Stock, Warrants, SEC Filing, Institutional Investor, Equity Stake, Passive Investment